Significant events impacting healthcare over the last several years have been associated with escalating rates of healthcare-associated infections. This has resulted in increased efforts to reinstitute well-established and evidence-based infection prevention practices, particularly for central line associated bloodstream infections. However, implementation of prevention initiatives beyond central lines has not received the same level of acknowledgement and response as being a considerable risk to patients. This article, authored by infection prevention, infectious disease, and vascular access professionals, provides emerging perspectives and technical aspects associated with the complete lifecycle of a vascular access device. The intent is to provide insight and perspective into enhancing current IP practices in the acute care hospital setting. This will also help prepare hospitals for upcoming broader surveillance and intervention activities aimed at reducing Hospital Onset Bacteremia and Fungemia (HOB) associated with all types of vascular access devices.

中文翻译：

---

预防血管通路装置相关的医院发病菌血症和真菌血症：新兴观点综述和技术方面的综合

过去几年影响医疗保健的重大事件与医疗保健相关感染率的上升有关。这导致人们加大努力，重新建立完善的、基于证据的感染预防措施，特别是针对中心静脉导管相关的血流感染。然而，在中心线之外实施预防举措并未得到同等程度的认可和响应，因为这对患者构成了相当大的风险。本文由感染预防、传染病和血管通路专业人士撰写，提供了与血管通路装置的完整生命周期相关的新兴观点和技术方面。其目的是为加强急症护理医院环境中当前的知识产权实践提供见解和视角。这也将有助于医院为即将开展的更广泛的监测和干预活动做好准备，这些活动旨在减少与所有类型的血管通路装置相关的医院发病菌血症和真菌血症 (HOB)。